University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

R21/Matrix-M in African Children Against Clinical Malaria

Phase 3

Active, not recruiting

Conditions: Malaria

Interventions: Biological: R21/Matrix-M
Biological: Rabies vaccine or Hepatitis A vaccine

First Posted Date: 2021-01-12

Last Posted Date: 2024-05-17

Lead Sponsor: University of Oxford

Target Recruit Count: 4800

Registration Number: NCT04704830

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Phase 1

Completed

Conditions: RVF
Rift Valley Fever

Interventions: Other: Saline
Biological: ChAdOx1 RVF

First Posted Date: 2020-12-17

Last Posted Date: 2023-02-06

Lead Sponsor: University of Oxford

Target Recruit Count: 30

Registration Number: NCT04672824

Locations: 🇺🇬
MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda

Online Culture for Mental Health in People Aged 16-24

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Other: WofB
Other: Ashmolean Website

First Posted Date: 2020-12-11

Last Posted Date: 2022-05-06

Lead Sponsor: University of Oxford

Target Recruit Count: 463

Registration Number: NCT04663594

Locations: 🇬🇧
Ashmolean Museum Website, Oxford, Oxfordshire, United Kingdom

Saving Babies Lives

Not Applicable

Completed

Conditions: Perinatal Mortality

Interventions: Behavioral: No Saving Babies Lives Programme
Behavioral: Saving Babies Lives Programme

First Posted Date: 2020-12-11

Last Posted Date: 2024-03-12

Lead Sponsor: University of Oxford

Target Recruit Count: 24040

Registration Number: NCT04663620

Locations: 🇰🇭
Angkor Hospital for Children, Siem Reap, Cambodia

7-day Simvastatin and Emotional Processing

Phase 1

Completed

Conditions: Inflammation
Depression

Interventions: Drug: Simvastatin 20mg
Drug: Placebo

First Posted Date: 2020-12-03

Last Posted Date: 2022-11-03

Lead Sponsor: University of Oxford

Target Recruit Count: 53

Registration Number: NCT04652089

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

Phase 1

Completed

Conditions: Locally Advanced Non-Small Cell Lung Cancer

Interventions: Drug: Atovaquone Oral Suspension
Drug: Standard of care chemotherapy
Radiation: Standard of care radiotherapy

First Posted Date: 2020-12-01

Last Posted Date: 2024-11-25

Lead Sponsor: University of Oxford

Target Recruit Count: 21

Registration Number: NCT04648033

Locations: 🇬🇧
Western General Hospital, NHS Lothian, Edinburgh, United Kingdom
🇬🇧
Guy's and St Thomas', London, United Kingdom
🇬🇧
Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia

Recruiting

Conditions: Acute Febrile Illness

First Posted Date: 2020-11-16

Last Posted Date: 2024-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 7200

Registration Number: NCT04629053

Locations: 🇧🇩
Building Resources Across Communities (BRAC), Dhaka, Bangladesh
🇱🇦
Laos-Oxford-Mahosot Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic
🇹🇭
Chiangrai Clinical Research Unit (CCRU), Chiang Rai, Thailand

and more 1 locations

Defining Causes of Deaths in South and Southeast Asia

Recruiting

Conditions: Cause of Neonatal Death
Cause of Mortality
Cause of Maternal Death
Cause of Child Death
Cause of Adult Death

First Posted Date: 2020-10-20

Last Posted Date: 2023-01-20

Lead Sponsor: University of Oxford

Target Recruit Count: 2000

Registration Number: NCT04595656

Locations: 🇧🇩
Building Resources Across Communities (BRAC), Dhaka, Bangladesh
🇰🇭
Action for Health Development (AHEAD), Battambang, Cambodia
🇱🇦
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Vientiane, Lao People's Democratic Republic

and more 2 locations

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

Phase 1

Completed

Conditions: HIV

Interventions: Biological: ChAdOx1.tHIVconsv1 (C1)
Biological: MVA.tHIVconsv3 (M3)
Biological: MVA.tHIVconsv4 (M4)

First Posted Date: 2020-10-14

Last Posted Date: 2022-08-11

Lead Sponsor: University of Oxford

Target Recruit Count: 13

Registration Number: NCT04586673

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

The Microbiology of Pleural Infection

Completed

Conditions: Pleural Infection
Pleural Infection Bacterial

Interventions: Other: Not applicable. Observational study. Retrospective analysis of samples.

First Posted Date: 2020-09-29

Last Posted Date: 2020-10-01

Lead Sponsor: University of Oxford

Target Recruit Count: 251

Registration Number: NCT04569110

Locations: 🇬🇧
Laboratory of Pleural Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy